1. Home
  2. ZLAB vs FLNC Comparison

ZLAB vs FLNC Comparison

Compare ZLAB & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • FLNC
  • Stock Information
  • Founded
  • ZLAB 2013
  • FLNC 2018
  • Country
  • ZLAB China
  • FLNC United States
  • Employees
  • ZLAB N/A
  • FLNC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • FLNC Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • FLNC Miscellaneous
  • Exchange
  • ZLAB Nasdaq
  • FLNC Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • FLNC 802.6M
  • IPO Year
  • ZLAB 2017
  • FLNC 2021
  • Fundamental
  • Price
  • ZLAB $32.54
  • FLNC $8.17
  • Analyst Decision
  • ZLAB Buy
  • FLNC Buy
  • Analyst Count
  • ZLAB 5
  • FLNC 18
  • Target Price
  • ZLAB $54.28
  • FLNC $8.58
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • FLNC 6.2M
  • Earning Date
  • ZLAB 08-05-2025
  • FLNC 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • FLNC N/A
  • EPS Growth
  • ZLAB N/A
  • FLNC N/A
  • EPS
  • ZLAB N/A
  • FLNC N/A
  • Revenue
  • ZLAB $418,326,000.00
  • FLNC $2,329,871,000.00
  • Revenue This Year
  • ZLAB $44.07
  • FLNC $3.61
  • Revenue Next Year
  • ZLAB $49.13
  • FLNC $25.79
  • P/E Ratio
  • ZLAB N/A
  • FLNC N/A
  • Revenue Growth
  • ZLAB 43.72
  • FLNC 6.08
  • 52 Week Low
  • ZLAB $16.01
  • FLNC $3.46
  • 52 Week High
  • ZLAB $44.34
  • FLNC $24.00
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • FLNC 68.98
  • Support Level
  • ZLAB $34.26
  • FLNC $6.06
  • Resistance Level
  • ZLAB $35.72
  • FLNC $8.92
  • Average True Range (ATR)
  • ZLAB 1.12
  • FLNC 0.59
  • MACD
  • ZLAB -0.54
  • FLNC 0.18
  • Stochastic Oscillator
  • ZLAB 3.83
  • FLNC 78.68

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About FLNC Fluence Energy Inc.

Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: